Literature DB >> 10505706

Sulfamethizole capsules containing contrast medium for assessment of gastric emptying in functional dyspepsia patients.

T Suzuki1, Y Yamamoto, K Abe, M Hirano, H Oka.   

Abstract

The usefulness of sulfamethizole capsules containing contrast medium in gastric emptying tests for functional dyspepsia was evaluated in five healthy volunteers and nine patients with dysmotility-like symptoms. Each subject swallowed 15 capsules with a liquid, food, and at 0, 15, 30, 45, 60, 90, and 120 min, the capsule position and size were monitored fluoroscopically for 30 sec and radiograms were obtained. Blood sulfamethizole concentrations were also measured at the same time. Visualized capsule movement from the proximal to distal stomach up to 60 min was faster in the patients, whereas in the later digestion period, proximal stomach emptying in the patients was delayed significantly (P < 0.05), and the number of capsules remaining in the distal stomach at 120 min was significantly larger in the patients (P < 0.05). This test method was evaluated as being useful in monitoring solid emptying in normal and pathophysiologic conditions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10505706     DOI: 10.1023/a:1018809731887

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  26 in total

1.  Effect of distension and feeding on phasic changes in human proximal gastric tone.

Authors:  N K Ahluwalia; D G Thompson; J Barlow
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

2.  Abnormal intragastric distribution of food during gastric emptying in functional dyspepsia patients.

Authors:  L E Troncon; R J Bennett; N K Ahluwalia; D G Thompson
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

3.  Evidence for hypomotility in non-ulcer dyspepsia: a prospective multifactorial study.

Authors:  B Waldron; P T Cullen; R Kumar; D Smith; J Jankowski; D Hopwood; D Sutton; N Kennedy; F C Campbell
Journal:  Gut       Date:  1991-03       Impact factor: 23.059

4.  Manometric evaluation of functional upper gut symptoms.

Authors:  J R Malagelada; V Stanghellini
Journal:  Gastroenterology       Date:  1985-05       Impact factor: 22.682

5.  Sulfamethizole capsule method. A new method for assessing gastric emptying of solids.

Authors:  T Asada; M Murakami; Y Sako; Y Fukushima; Y Yonekura; J Konishi; T Kita; T Miyake; T Asada
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

6.  Visceral perception in health and functional dyspepsia. Crossover study of gastric distension with placebo and domperidone.

Authors:  M Bradette; P Pare; P Douville; A Morin
Journal:  Dig Dis Sci       Date:  1991-01       Impact factor: 3.199

7.  Electrogastrographic study of patients with unexplained nausea, bloating, and vomiting.

Authors:  C H You; K Y Lee; W Y Chey; R Menguy
Journal:  Gastroenterology       Date:  1980-08       Impact factor: 22.682

8.  Measurement of gastric emptying in dyspeptic patients: effect of a new gastrokinetic agent (cisapride).

Authors:  R Jian; F Ducrot; C Piedeloup; J Y Mary; Y Najean; J J Bernier
Journal:  Gut       Date:  1985-04       Impact factor: 23.059

9.  Patterns of gastric emptying in dysmotility-like dyspepsia.

Authors:  M Bortolotti; L Bolondi; V Santi; P Sarti; F Brunelli; L Barbara
Journal:  Scand J Gastroenterol       Date:  1995-05       Impact factor: 2.423

10.  Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride.

Authors:  R Jian; F Ducrot; A Ruskone; S Chaussade; J C Rambaud; R Modigliani; J D Rain; J J Bernier
Journal:  Dig Dis Sci       Date:  1989-05       Impact factor: 3.199

View more
  1 in total

1.  Edrophonium provocative testing for the evaluation of upper gastrointestinal hypersensitivity in patients with nonulcer dyspepsia.

Authors:  Shinichi Tsutsui; Kazunori Mine; Masanori Handa; Haruo Hayashi; Masako Hosoi; Naoko Kinukawa; Chiharu Kubo
Journal:  Dig Dis Sci       Date:  2006-07-26       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.